期刊文献+

缬沙坦在特发性心房颤动复律后维持窦性心律中的作用

暂未订购
导出
摘要 目的观察缬沙坦在特发性心房颤动复律后维持窦性心律中的作用。方法选择特发性心房颤动成功转律患者56人,随机分为治疗组和对照组。治疗组在常规治疗基础上加缬沙坦片80mg/d,随访6个月,随访终点是心房颤动复发。若病人出现症状即进院,即刻行心电图和24小时动态心电图检查。所有病人在半年后行超声心动图和24小时动态心电图检查。结果治疗组共有4例心房颤动复发,对照组13例复发,治疗组心房颤动复发率较对照组明显降低(14%vs46%P<0.05),房性早搏、左房直径及左室射血分数两组间无明显差异。结论缬沙坦可降低特发性房颤病人复律后的复发率。
出处 《心脑血管病防治》 2006年第5期303-304,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献7

  • 1Kalus JS,Coleman CI,White CM.The impact of suppressing the Renin-Angiotensin system on atrial fibrillation.J Clin Pharmacol,2006,46(1):21-28.
  • 2Goette A,Honeycutt C,Langberg JJ.Electrical Remodeling in Atrial Fibrillation:Time Course and Mechanisms.Circulation,1996,94(11):2968-2974.
  • 3Nakashima H,Kumagai K,Urata H,et al.Angiotensin Ⅱ Antagonist Prevents Electrical Remodeling in Atrial Fibrillation.Circulation,2000,101(22):2612-2617.
  • 4Schoonderwoerd BA,Van Gelder IC,Van Veldhuisen DJ,et al.Electrical and structural remodeling:role in the genesis and maintenance of atrial fibrillation.Prog Cardiovasc Dis,2005,48(3):153-168.
  • 5Boldt A,Wetzel U,Weigl J,et al.Expression of angiotensin Ⅱ receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease.J Am Coll Cardiol,2003,42(10):1785-1792.
  • 6Kumagai K,Nakashima H,Urata H,et al.Effects of angiotensin Ⅱ type Ⅰ receptor antagonist on electrical and structural remodeling in atrial fibrillation.J Am Coll Cardiol,2003,41(12):2197-2204.
  • 7Madrid AH,Escobar C,Rebollo JM,et al.Angiotensin receptor blocker as adjunctiove therapy for rhythm control in atrial fibrillation:results of the irbesartan-amiodarone trial.Card Electrophysiol Rev,2003,7(3):243-246.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部